Lindsey Rolfe insider trades: Clovis Oncology (CLVS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lindsey reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | CLVS | ↓ Sell | 4,261 | $0.98 | $4K | Direct | Nov 3, 2022 (1d) |
| Sep 2, 2022 | CLVS | ↓ Sell | 2,545 | $1.20 | $3K | Direct | Sep 6, 2022 (4d) |
| Aug 2, 2022 | CLVS | ↓ Sell | 4,330 | $1.46 | $6K | Direct | Aug 3, 2022 (1d) |
| Jun 2, 2022 | CLVS | ↓ Sell | 2,650 | $0.64 | $2K | Direct | Jun 3, 2022 (1d) |
| May 2, 2022 | CLVS | ↓ Sell | 4,252 | $1.97 | $8K | Direct | May 3, 2022 (1d) |
| Mar 2, 2022 | CLVS | ↓ Sell | 10,945 | $1.87 | $20K | Direct | Mar 3, 2022 (1d) |
| Feb 2, 2022 | CLVS | ↓ Sell | 4,514 | $1.94 | $9K | Direct | Feb 3, 2022 (1d) |
| Dec 2, 2021 | CLVS | ↓ Sell | 346 | $3.00 | $1K | Direct | Dec 3, 2021 (1d) |
| Nov 2, 2021 | CLVS | ↓ Sell | 4,209 | $4.55 | $19K | Direct | Nov 3, 2021 (1d) |
| Sep 2, 2021 | CLVS | ↓ Sell | 347 | $4.89 | $2K | Direct | Sep 3, 2021 (1d) |
| Aug 3, 2021 | CLVS | ↓ Sell | 4,195 | $4.82 | $20K | Direct | Aug 3, 2021 (0d) |
| Jun 3, 2021 | CLVS | ↓ Sell | 322 | $5.63 | $2K | Direct | Jun 3, 2021 (0d) |
| May 4, 2021 | CLVS | ↓ Sell | 4,501 | $5.54 | $25K | Direct | May 4, 2021 (0d) |
| Mar 2, 2021 | CLVS | ↓ Sell | 661 | $6.29 | $4K | Direct | Mar 3, 2021 (1d) |
| Feb 2, 2021 | CLVS | ↓ Sell | 11,813 | $7.97 | $94K | Direct | Feb 3, 2021 (1d) |
| Dec 21, 2020 | CLVS | ↓ Sell | 1,728 | $5.68 | $10K | Direct | Dec 23, 2020 (2d) |
| Dec 3, 2020 | CLVS | ↓ Sell | 661 | $4.89 | $3K | Direct | Dec 7, 2020 (4d) |
| Nov 3, 2020 | CLVS | ↓ Sell | 1,920 | $4.93 | $9K | Direct | Nov 5, 2020 (2d) |
| Sep 21, 2020 | CLVS | ↓ Sell | 1,747 | $6.85 | $12K | Direct | Sep 23, 2020 (2d) |
| Sep 3, 2020 | CLVS | ↓ Sell | 628 | $5.30 | $3K | Direct | Sep 8, 2020 (5d) |
| Aug 3, 2020 | CLVS | ↓ Sell | 1,899 | $5.92 | $11K | Direct | Aug 5, 2020 (2d) |
| Jun 22, 2020 | CLVS | ↓ Sell | 1,728 | $6.74 | $12K | Direct | Jun 23, 2020 (1d) |
| Jun 3, 2020 | CLVS | ↓ Sell | 680 | $7.03 | $5K | Direct | Jun 5, 2020 (2d) |
| May 5, 2020 | CLVS | ↓ Sell | 1,677 | $8.10 | $14K | Direct | May 7, 2020 (2d) |
| Mar 20, 2020 | CLVS | ↓ Sell | 1,728 | $4.60 | $8K | Direct | Mar 23, 2020 (3d) |
| Mar 3, 2020 | CLVS | ↓ Sell | 687 | $7.20 | $5K | Direct | Mar 5, 2020 (2d) |
| Feb 4, 2020 | CLVS | ↓ Sell | 7,503 | $8.41 | $63K | Direct | Feb 6, 2020 (2d) |
| Dec 20, 2019 | CLVS | ↓ Sell | 1,729 | $11.30 | $20K | Direct | Dec 26, 2019 (6d) |
| Dec 3, 2019 | CLVS | ↓ Sell | 674 | $14.60 | $10K | Direct | Dec 5, 2019 (2d) |
| Sep 20, 2019 | CLVS | ↓ Sell | 1,744 | $4.80 | $8K | Direct | Sep 24, 2019 (4d) |
| Sep 4, 2019 | CLVS | ↓ Sell | 716 | $5.21 | $4K | Direct | Sep 6, 2019 (2d) |
| Jun 20, 2019 | CLVS | ↓ Sell | 1,728 | $14.70 | $25K | Direct | Jun 24, 2019 (4d) |
| Jun 4, 2019 | CLVS | ↓ Sell | 655 | $15.07 | $10K | Direct | Jun 6, 2019 (2d) |
| Mar 20, 2019 | CLVS | ↓ Sell | 1,729 | $26.13 | $45K | Direct | Mar 21, 2019 (1d) |
| Mar 5, 2019 | CLVS | ↓ Sell | 1,731 | $29.29 | $51K | Direct | Mar 6, 2019 (1d) |
| Dec 20, 2018 | CLVS | ↓ Sell | 1,728 | $17.72 | $31K | Direct | Dec 26, 2018 (6d) |
| Dec 4, 2018 | CLVS | ↓ Sell | 284 | $21.23 | $6K | Direct | Dec 6, 2018 (2d) |
| Oct 28, 2015 | CLVS | ↓ Sell10b5-1 | 4,000 | $98.02 | $392K | Direct | Oct 30, 2015 (2d) |
| Oct 5, 2015 | CLVS | ↓ Sell10b5-1 | 4,000 | $93.04 | $372K | Direct | Oct 7, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lindsey Rolfe's insider trades
Lindsey Rolfe is See Remarks at Clovis Oncology (CLVS). Since Oct 5, 2015, Lindsey has reported no open-market purchases and 39 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (57% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (48 filings), grants and awards (17 filings), shares withheld for taxes (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.